ETOPOPHOS PRESERVATIVE FREE
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Feb 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13m ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ETOPOPHOS PRESERVATIVE FREE is an injectable small-molecule formulation approved in 1998 for parenteral administration. The preservative-free designation indicates a specialized formulation designed to minimize injection-site reactions and systemic toxicity. Specific indication and mechanism require clinical reference, but the product targets a defined patient population requiring intravenous chemotherapy or supportive care.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30), suggesting team focus is on lifecycle extension, generic defense, or transition planning rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and approaching LOE, opportunities on ETOPOPHOS are limited and likely focused on defending market share against generics or managing transition. This is a mature-stage product role suited for professionals with lifecycle management or generic defense experience rather than launch or growth specialists.
Brand ManagerProduct Manager
Worked on ETOPOPHOS PRESERVATIVE FREE at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.